Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment

Table 2 Baseline demographics of participants with hepatitis C/human immunodeficiency virus coinfection who had baseline, during, and post-treatment Beck’s Depression Inventory scoring analyzed n (%)

Demographic	Sofosbuvir-based therapy (n = 50)	Interferon-based therapy (n = 26)	P value
Age, median	58	47
Male	37 (74)	22 (84)	0.79
African American	42 (84)	11 (42)	0.0004
Fibrosis			0.00132
F0-1	35 (70)	10 (38)
F2-4	15 (30)	16 (62)
SVR	49 (98)	13 (50)	0.0001
Baseline mental health disease	15 (30)	15 (58)	0.0264

SVR: Sustained virologic response.